Interferon beta-1a as adjunctive treatment for multifocal motor neuropathy: An open label trial

Journal of the Peripheral Nervous System

Volumn 14, Issue 3, 2009, Pages 201-202

  Radziwill, Alexander J ^a   Botez, Stephan A ^a   Novy, Jan ^a   Kuntzer, Thierry ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

CLINICAL TRIAL; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; DRUG TREATMENT FAILURE; HEALTH CARE COST; HUMAN; LETTER; MOTOR NEUROPATHY; NERVE CONDUCTION; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

CHEMOTHERAPY, ADJUVANT; DRUG THERAPY, COMBINATION; ELECTROPHYSIOLOGY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INTERFERON-BETA; PILOT PROJECTS; POLYNEUROPATHIES;

EID: 70449513839     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/j.1529-8027.2009.00232.x     Document Type: Letter

References (5)

1. Kuntzer T, Radziwill AJ, Botez SA (2007). Clinical background of the multifocal motor neuropathy: the Lausanne experience. Schweiz Arch Neurol Psychiatr 158 : 57 64.
2. Martina IS, van Doorn PA, Schmitz PIM, Meulstee J, van der Meché FGA (1999). Chronic motor neuropathies: response to interferon-β1a after failure of conventional therapies. J Neurol Neurosurg Psychiatr 66 : 197 201.
3. Umapathi T, Hughes RAC, Nobile-Orazio E, Léger JM (2009). Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy. Cochrane Database Syst Rev 1 : CD003217.
4. Van den Berg LH (2007). Multifocal motor neuropathy. IVIg and other therapies. Schweiz Arch Neurol Psychiatr 158 : 86 89.
5. Van den Berg-Vos RM, Van den Berg LH, Franssen H, Van Doorn PA, Merkies ISJ, Wokke JHJ (2000). Treatment of multifocal motor neuropathy with interferon- ß1A. Neurology 54 : 1518 1521.